Biologics

FDA Approves Enhertu as Neoadjuvant, Adjuvant Treatment for Breast Cancer

Physician’s Briefing

FDA Approves Enhertu as Neoadjuvant, Adjuvant Treatment for Breast Cancer

22 May 2026

2 min read

ATS: Tezepelumab Reduces Asthma Exacerbations Across Asthma Phenotypes

Physician’s Briefing

ATS: Tezepelumab Reduces Asthma Exacerbations Across Asthma Phenotypes

18 May 2026

2 min read

FDA Approves Label Expansion for Vyvgart, Vyvgart Hytrulo

Physician’s Briefing

FDA Approves Label Expansion for Vyvgart, Vyvgart Hytrulo

15 May 2026

1 min read

Read More

Clinical Briefing Report

clinicalbriefingreport.com